<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Cardiff Oncology Inc (CRDF)</title>
    <description>Latest news, press releases, and SEC filings for Cardiff Oncology Inc (CRDF)</description>
    <link>https://caymanjournal.com/stock/CRDF</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 22:46:07 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/CRDF/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>DEF 14A — Cardiff Oncology, Inc.</title>
      <description># 🧾 What This Document Is
This is a **DEF 14A**, also known as a **Proxy Statement**. Cardiff Oncology is sending this to its shareholders ahead of the annual meeting to explain what will be voted on and provide important company information. Think of it as an agenda and info packet for the company</description>
      <link>https://caymanjournal.com/stock/CRDF/sec-filing/0001213037-26-000006</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/CRDF/sec-filing/0001213037-26-000006</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>